GlassScriptPhysician profile
Kory Dee Miskin
NPI 1215376058
$3,514.86
in general payments reported to CMS, 2019-2025
21 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,610 · 2020: $312 · 2021: $198 · 2022: $155 · 2023: $92.45 · 2024: $775 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946 · Travel and Lodging: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.71 |
| Travel and Lodging | $293.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,705.82 | 2019-2025 | Salvation, Easyfuse, Hoffmann |
| Abbvie INC. | $164.18 | 2021-2024 | |
| Kerecis Limited | $103.38 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $65.46 | 2020 | |
| Kci USA, INC. | $61.54 | 2021-2023 | V.A.C. Dermatac, Activ.A.C. |
| Integra Lifesciences Corporation | $54.86 | 2019-2024 | Tcc-Ez |
| Treace Medical Concepts, INC. | $46.70 | 2024 | |
| Cashflow Solutions, LLC | $45.85 | 2022 | |
| Paratek Pharmaceuticals, INC. | $38.54 | 2020-2023 | Nuzyra |
| Aroa Biosurgery Incorporated | $30.51 | 2022 | |
| Smith+Nephew, INC. | $24.55 | 2020 | |
| Bone Support INC. | $20.38 | 2024 | Ceramentbone Void Filler, Cerament G |
| Daiichi Sankyo INC. | $19.93 | 2019 | |
| Horizon Therapeutics Plc | $19.56 | 2020 | |
| Polynovo North America LLC | $19.18 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $18.99 | 2025 | Apligraf |
| Mimedx Group, INC. | $17.37 | 2025 | |
| Janssen Pharmaceuticals, INC | $16.50 | 2023 | Xarelto |
| Midsouth Orthopedics INC. | $16.34 | 2024 | |
| Dexcom, INC. | $13.94 | 2022 | |
| Amgen INC. | $11.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kory Miskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.